The DOI matches its Crossref record; 307 of the 307 references it cites were found in a registry or an index.
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–307 of 307
Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors
Manley, P. W., Furet, P., Bold, G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020899q · Cited by 103
Čačić, M., Trkovnik, M., Čačić, F., & Has-Schon, E. (2006) · Molecules · doi:10.3390/11010134 · Cited by 103
Synthesis and Antifungal Activity of Novel Bis(dithiocarbamate) Derivatives of Glycerol
Len, C., Boulogne-Merlot, A.-S., Postel, D., Ronco, G., Villa, P., Goubert, C., Jeufrault, E., Mathon, B., & Simon, H. (1996) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf950751y · Cited by 102
A structural view of microtubule dynamics
Nogales, E. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050012 · Cited by 101
Urasaki, Y., Laco, G. S., Pourquier, P., Takebayashi, Y., Kohlhagen, G., Gioffre, C., Zhang, H., Chatterjee, D., Pantazis, P., & Pommier, Y. G. (2001) · PubMed · Cited by 99
Mapping the Binding Site of Colchicinoids on β-Tubulin
Bai, R., Covell, D. G., Pei, X., Ewell, J. B., Nguyen, N. Y., Brossi, A. R., & Hamel, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005299200 · Cited by 97
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.025 · Cited by 96
Zhu, G., Conner, S. E., Zhou, X., Shih, C., Li, T., Anderson, B. D., Brooks, H. B., Campbell, R. M., Considine, E. L., Dempsey, J. A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0256169 · Cited by 96
Macrocyclic Histone Deacetylase Inhibitors
Mwakwari, S. C., Patil, V., Guerrant, W., & Oyelere, A. K. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610792232079 · Cited by 96
Kuo, G., DeAngelis, A., Emanuel, S. L., Wang, A., Zhang, Y., Connolly, P. J., Chen, X., Gruninger, R. H., Rugg, C. A., Fuentes‐Pesquera, A. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040214h · Cited by 96
Roesner, M., Capraro, H., Jacobson, A. E., Atwell, L., Brossi, A. R., IORIO, M. A., Williams, T. H., Sik, R. H., & Chignell, C. F. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00135a005 · Cited by 95
Liu, X., Tee, H.-W., & Go, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.006 · Cited by 95
Gregson, S. J., Howard, P. W., Gullick, D. R., Hamaguchi, A., Corcoran, K. E., Brooks, N. A., Hartley, J. A., Jenkins, T. C., Patel, S., Guille, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030897l · Cited by 92
Saavedra, J. E., Srinivasan, A., Buzard, G. S., Davies, K. M., Waterhouse, D. J., Inami, K., Wilde, T. C., Citro, M. L., Cuellar, M. E., Deschamps, J. R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050700k · Cited by 92
Exemestane, a new steroidal aromatase inhibitor of clinical relevance
Lombardi, P. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00096-0 · Cited by 91
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) mice
Williams, J. L., Kashfi, K., Ouyang, N., Soldato, P. D., Kopelovich, L., & Rigas, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.015 · Cited by 90
Bazzaro, M., Anchoori, R. K., Mudiam, M. K. R., Issaenko, O. A., Kumar, S. K., Karanam, B., Lin, Z., Vogel, R. I., Gavioli, R., Destro, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100589p · Cited by 90
Xiao, Z., Xiao, Y.-D., Feng, J., Golbraikh, A., Tropsha, A., & Lee, K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0105427 · Cited by 90
Beaulieu, P. L., Bousquet, Y., Gauthier, J. B., Gillard, J. R., Marquis, M., McKercher, G., Pellerin, C., Valois, S., & Kukolj, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040134d · Cited by 89
Agbandje, M., Jenkins, T. C., McKENNA, R. V., Reszka, A. P., & Neidle, S. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a010 · Cited by 89
Ma, J., Li, S., Reed, K., Guo, P., & Gallo, J. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048587 · Cited by 87
AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
Sun, X., Wong, J. R., Song, K. S., Hu, J., Garlid, K., & Chen, L. B. (1994) · PubMed · Cited by 83
Li, Q., Huang, J. S., Wang, Q., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.069 · Cited by 82
Synthesis and evaluation of geldanamycin–testosterone hybrids
Kuduk, S. D., Harris, C. R., Zheng, F. F., Sepp‐Lorenzino, L., Ouerfelli, O., Rosen, N. X., & Danishefsky, S. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00208-0 · Cited by 82
Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin
Hamel, E., & Lin, C. M. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90163-6 · Cited by 82
The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
Zhang, X., Zhang, J., Tong, L., Luo, Y., Su, M., Zang, Y., Li, J. X., Lu, W. P., & Chen, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.049 · Cited by 82
Buriez, O., Heldt, J., Labbé, É., Vessières, A., Jaouen, G., & Amatore, C. A. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800507 · Cited by 82
Abdel‐Hamid, M. K., ABDEL‐HAFEZ, A. A., El‐Koussi, N. A., Mahfouz, N. M., Innocenti, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.044 · Cited by 80
Kashfi, K., Borgo, S., Williams, J. L., Chen, J., Gao, J., Glekas, A., Benedini, F., Soldato, P. D., & Rigas, B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075994 · Cited by 80
Xue, H., Lu, X., Zheng, P., Liu, L., Han, C., Hu, J., Liu, Z., Ma, T., Li, Y., Wang, L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901653e · Cited by 79
Hochhauser, D., Meyer, T., Spanswick, V. J., Wu, J., Clingen, P. H., Loadman, P. M., Cobb, M., Gumbrell, L. A., Beǵent, R. H. J., Hartley, J. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1315 · Cited by 79
Yang, W., Va, P., Wong, M.-Y., Zhang, H.-L., & Xiang, Y. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.020966 · Cited by 79
Fadeyi, O., Adamson, S. T., Myles, E. L., & Okoro, C. O. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.078 · Cited by 77
Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivoevidence
Lund, T. D., Blake, C., Bu, L., Hamaker, A., & Lephart, E. D. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-4 · Cited by 77
Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice
Huang, G. S., Lopez-Barcons, L. A., Freeze, B. S., Smith, A. B., Goldberg, G. L., Horwitz, S. B., & McDaid, H. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0229 · Cited by 76
N’soukpoé-Kossi, C. N., Descôteaux, C., Asselin, É., Tajmir‐Riahi, H., & Bérubé, G. (2007) · DNA and Cell Biology · doi:10.1089/dna.2007.0669 · Cited by 75
Wang, J., Shen, Y., Hu, W., Hsieh, M.-C., Lin, F., Hsu, M., & Hsu, M.-H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050956q · Cited by 74
Levinson, W. E., Faras, A. J., Woodson, B. A., Jackson, J., & Bishop, J. M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.164 · Cited by 73
Kumar, K., Sagar, S., Esau, L. E., Kaur, M., & Kumar, V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.008 · Cited by 71
Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.
Leteurtre, F., Madalengoitia, J., Orr, A., Guzi, T. J., Lehnert, E. K., Macdonald, T. L., Pommier, Y. G., & Cuzi, T. J. (1992) · PubMed · Cited by 71
Devivar, R. V., Kawashima, E., Revankar, G. R., Breitenbach, J. M., Kreske, E. D., Drach, J. C., & Townsend, L. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00044a015 · Cited by 70
New insights into microtubule structure and function from the atomic model of tubulin
Downing, K. H., & Nogales, E. (1998) · European Biophysics Journal · doi:10.1007/s002490050153 · Cited by 67
Hu, C., Solomon, V. R., Ulíbarri, G., & Lee, H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.076 · Cited by 67
Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
Zhan, P., & Liu, X. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453266 · Cited by 66
Non-Peptide Macrocyclic Histone Deacetylase Inhibitors
Oyelere, A. K., Chen, P. C., Guerrant, W., Mwakwari, S. C., Hood, R., Zhang, Y., & Fan, Y. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801128g · Cited by 64
de Groot, D. J. A., van der Deen, M., Le, T. K. P., Regeling, A., de Jong, S., & de Vries, E. G. E. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604010 · Cited by 64
Schultz, R. M., Merriman, R. L., Toth, J. E., Zimmermann, J. E., Hertel, L. W., Andis, S. L., Dudley, D. E., Rutherford, P., Tanzer, L. R., & Grindey, G. B. (1993) · PubMed · Cited by 63
Antitumor activities of synthetic and natural stilbenes through antiangiogenic action
Kimura, Y., Sumiyoshi, M., & Baba, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00948.x · Cited by 63
Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni, C., Marchini, S., Cozzi, P., Galliera, E., Ragg, E. M., Colombo, T., Battaglia, R., Howard, M., D’Incalci, M., & Broggini, M. (2002) · PubMed · Cited by 62
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor
Dorr, R. T., Dvorakova, K., Snead, K., Alberts, D. S., Salmon, S. E., & Pettit, G. R. (1996) · Investigational New Drugs · doi:10.1007/bf00210783 · Cited by 62
Baraldi, P. G., Balboni, G., Cacciari, B., Guiotto, A., Manfredini, S., Romagnoli, R., Spalluto, G., Thurston, D. E., Howard, P. W., Bianchi, N., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991033w · Cited by 61
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group
Vickers, C. J., Olsen, C. A., Leman, L. J., & Ghadiri, M. R. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300081u · Cited by 60
Selective cell culture of primary breast carcinoma.
Dairkee, S. H., Deng, G., Stampfer, M. R., Waldman, F. M., & Hs, S. (1995) · PubMed · Cited by 60
Design and synthesis of C-8 linked pyrrolobenzodiazepine–naphthalimide hybrids as anti-tumour agents
Kamal, A., REDDY, B. S. N., Reddy, G. S. K., & Ramesh, G. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00326-8 · Cited by 60
17β‐Estradiol‐Associated Stealth‐Liposomal Delivery of Anticancer Gene to Breast Cancer Cells
Reddy, B. S., & Banerjee, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501793 · Cited by 59
Design, synthesis and biological evaluation of estradiol–chlorambucil hybrids as anticancer agents
Gupta, A. K., Saha, P., Descôteaux, C., Leblanc, V., Asselin, É., & Bérubé, G. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.053 · Cited by 56
2-Hydroxy-4,6-diamino-[1,3,5]triazines: A Novel Class of VEGF-R2 (KDR) Tyrosine Kinase Inhibitors
Baindur, N., Chadha, N. K., Brandt, B. M., Asgari, D., Patch, R. J., Schalk‐Hihi, C., Carver, T. E., Petrounia, I. P., Baumann, C. A., Ott, H. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049372z · Cited by 55
Canthin-6-one alkaloids from Eurycoma longifolia
Mitsunaga, K., Koike, K., Tanaka, T., Ohkawa, Y., Kobayashi, Y., Sawaguchi, T., & Ohmoto, T. (1994) · Phytochemistry · doi:10.1016/s0031-9422(00)90609-5 · Cited by 54
Hybrid α-bromoacryloylamido chalcones. Design, synthesis and biological evaluation
Romagnoli, R., Baraldi, P. G., Carriòn, M. D., Cruz‐López, O., Lopez-Cara, L. C., Balzarini, J. M., Hamel, E., Canella, A., Fabbri, E., Gambari, R., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.038 · Cited by 54
Hansen, M. R., Yun, S., & Hurley, L. H. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90273-2 · Cited by 54
Baine, M. K., Menon, V., Verdier‐Pinard, P., Smith, A. B., Angeletti, R. H., Fiser, A., Horwitz, S. B., & Xiao, H. (2009) · Biochemistry · doi:10.1021/bi901351q · Cited by 52
Chobanian, N. H., Greenberg, V. L., Gass, J. M., DeSimone, C. P., van Nagell, J. R., & Zimmer, S. G. (2004) · PubMed · Cited by 52
Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives
Zhang, H., Solomon, V. R., Hu, C., Ulíbarri, G., & Lee, H. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.04.007 · Cited by 51
dos Anjos, J. V., Filho, R. A. W. N., do Nascimento, S. C., Srivastava, R. M., de Melo, S. J., & Sinou, D. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.03.002 · Cited by 51
The binding of Isocolchicine to Tubulin
Hastie, S. B., Williams, R. C., Puett, D., & MACDONALD, T. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83481-0 · Cited by 49
Design and Synthesis of a Novel DNA−DNA Interstrand Adenine−Guanine Cross-Linking Agent
Zhou, Q. Y., Duan, W., Simmons, D. P., Shayo, Y., Raymond, M. A., Dorr, R. T., & Hurley, L. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005658r · Cited by 46
Hansen, M. R., Lee, S., Cassady, J. M., & Hurley, L. H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960319c · Cited by 45
Zhou, Y., Zhao, Y., Boyle, K. M. O., & Murphy, P. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.034 · Cited by 44
p53 acetylation enhances Taxol-induced apoptosis in human cancer cells
Kim, J. H., Yoon, E.-K., Chung, H. J., Park, S.-Y., Hong, K., Lee, C. H., Lee, Y.-S., Choi, K., Yang, Y. D., Kim, K., et al. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0772-8 · Cited by 44
Fan, Y.-H., Chen, H., Natarajan, A., Guo, Y., Harbinski, F., Iyasere, J., Christ, W. J., Aktaş, H., & Halperin, J. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.087 · Cited by 43
Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids
Mourad, M. A. E., Abdel‐Aziz, M., Abuo‐Rahma, G. E. A., & Farag, H. H. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.030 · Cited by 43
Kamal, Ä., Mallareddy, A., Ramaiah, M. J., Pushpavalli, S. N. C. V. L., Suresh, P., Kishor, C., Murty, J. N. S. R. C., Rao, N. S., Ghosh, S., Addlagatta, A., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.021 · Cited by 42
Karalı, N., Kocabalkanlı, A., Gürsoy, A., & Ateş, Ö. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01254-5 · Cited by 41
Development of distamycin-related DNA binding anticancer drugs
Marchini, S., Broggini, M., Sessa, C., & D’Incalci, M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1703 · Cited by 41
The therapeutic potential of aromatase inhibitors
Miller, W., & Jackson, J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.3.337 · Cited by 41
Gu, X., Ren, Z., Tang, X., Peng, H., Yuan-fang Ma, A., Lai, Y., Peng, S., & Zhang, Y. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.050 · Cited by 40
Gunaratnam, M., Green, C. J., Moreira, J. B., Moorhouse, A. D., Kèlland, L. R., Moses, J. E., & Neidle, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.018 · Cited by 40
Kritsanida, M., Magiatis, P., Skaltsounis, A., Peng, Y., Li, P., & Wennogle, L. P. (2009) · Journal of Natural Products · doi:10.1021/np9003905 · Cited by 40
Annonaceous acetogenins: The unrevealed area for cytotoxic and pesticidal activities
Gupta, A. R., Shah, D., Seth, N., Pandey, S. S., & Yadav, J. (2011) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.86299 · Cited by 40
A click chemistry approach to C3 symmetric, G-quadruplex stabilising ligands
Moses, J. E., Ritson, D. J., Zhang, F., Lombardo, C. M., Haider, S. M., Oldham, N. J., & Neidle, S. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c005055e · Cited by 38
Themsche, C. V., Parent, S., Leblanc, V., Descôteaux, C., Simard, A.-M., Bérubé, G., & Asselin, É. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0113 · Cited by 38
Kamal, A., Tekumalla, V., Krishnan, A., Pal‐Bhadra, M., & Bhadra, U. (2008) · ChemMedChem · doi:10.1002/cmdc.200700328 · Cited by 37
Hu, Y. C., Rahlfs, S., Mersch‐Sundermann, V., & Becker, K. (2007) · Biological Chemistry · doi:10.1515/bc.2007.023 · Cited by 36
Provencher-Mandeville, J., Debnath, C., Mandal, S. K., Leblanc, V., Parent, S., Asselin, É., & Bérubé, G. (2010) · Steroids · doi:10.1016/j.steroids.2010.09.004 · Cited by 36
Synthesis and antitumour activity of pyrene-linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids
Kamal, A., Ramesh, G., Srinivas, O., & Ramulu, P. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.050 · Cited by 36
Li, D., Wang, L., Cai, H., Zhang, Y., & Xu, J. (2012) · Molecules · doi:10.3390/molecules17067556 · Cited by 35
Cosentino, L., Redondo‐Horcajo, M., Zhao, Y., Santos, A. R., Chowdury, K. F., Vinader, V. M., Abdallah, Q., Abdel-Rahman, H. M., Chabert, J. F. D., Shnyder, S. D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301151t · Cited by 34
Anderson, W. M., Delinck, D. L., Benninger, L., Wood, J. M., Smiley, S. T., & Chen, L. B. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90144-l · Cited by 34
Parihar, S., Kumar, A., Chaturvedi, A. K., Sachan, N. K., Luqman, S., Changkija, B., Manohar, M., Prakash, O., Chanda, D., Khan, F., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.009 · Cited by 33
Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth
Mizuno, C. S., Paul, S., Suh, N., & Rimando, A. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.038 · Cited by 33
Hu, C., Solomon, V. R., Cano, P., & Lee, H. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.11.017 · Cited by 32
Marco-Contelles, J. L., & Soriano, E. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798184382 · Cited by 32
Ritson, D. J., & Moses, J. E. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.10.066 · Cited by 31
Zefirova, O. N., Nurieva, E. V., Shishov, D. V., Baskin, I. I., Fuchs, F., Lemcke, H., Schröder, F. G., Weiss, D. G., Zefirov, N. S., & Kuznetsov, S. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.040 · Cited by 30
Parihar, S., Gupta, A. K., Chaturvedi, A. K., Agarwal, J., Luqman, S., Changkija, B., Manohar, M., Chanda, D., Chanotiya, C. S., Shanker, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.03.012 · Cited by 28
Nabha, S. M., Mohammad, R. M., Wall, N. R., Dutcher, J. A., Salkini, B. M., Pettit, G. R., & Al-Katib, A. M. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200101000-00008 · Cited by 26
Kwok, Y., Zeng, Q., & Hurley, L. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13531 · Cited by 26
Aromatase inhibitors for breast cancer: different structures, same effects?
Ponzone, R., Mininanni, P., Cassina, E., Pastorino, F., & Sismondi, P. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0249 · Cited by 26
Bose, D. S., Idrees, M., Todewale, I. K., Jakka, N. M., & Rao, J. V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.014 · Cited by 25
Synthesis and biological evaluation of novel anticancer bivalent colchicine–tubulizine hybrids
Malysheva, Y. B., Combes, S., Allegro, D., Peyrot, V., Knochel, P., Gavryushin, A. E., & Fedorov, A. Y. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.072 · Cited by 24
Design, synthesis and identification of novel colchicine-derived immunosuppressant
Chang, D., Yoon, E.-Y., Lee, G., Kim, S.-O., Kim, W.-J., Kim, Y., Jung, J., An, H., & Suh, Y. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.054 · Cited by 23
Yamada, Y., Tamura, T., Yamamoto, N., Shimoyama, T., Ueda, Y., Murakami, H., Kusaba, H., Kamiya, Y., Saka, H., Tanigawara, Y., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0149-6 · Cited by 20
Tang, X., Gu, X., Ren, Z., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.005 · Cited by 17
Bradshaw, T. D., Wren, J., Bruce, M., Barrett, D. A., Leong, C.-O., Gaskell, M., Wright, E. K., Farmer, P. B., Henderson, C. J., Wolf, C. R., et al. (2008) · Pharmacology · doi:10.1159/000183846 · Cited by 17
Sienkiewicz, P., Bielawski, K., Bielawska, A., & Palka, J. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.001 · Cited by 16
Steroid Sulfatase Inhibitors: Their Potential in the Therapy of Breast Cancer
Nußbaumer, P., & Billich, A. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054866955 · Cited by 16
Cited by
Hybrid molecules: The privileged scaffolds for various pharmaceuticals
Shaveta, Mishra, S., & Singh, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.039 · Cited by 508
An overview of molecular hybrids in drug discovery
Bérubé, G. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1135125 · Cited by 338
1,2,3‐Triazole hybrids as anticancer agents: A review
Alam, M. M. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202100158 · Cited by 312
Metadata
- Authors
- Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 77
- Pages
- 422-487
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2951185063
- Cited by
- 435
- References
- 307
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.